This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_SKIN_EYELID_EXALLC for full statistics.
Carcinoma in situ of skin of eyelid, including canthus
CD2_INSITU_SKIN_EYELID
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
65 |
4. Check minimum number of eventsNone |
65 |
5. Include endpointsNone |
65 |
6. Filter based on genotype QC (FinnGen only) |
65 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis palpebrae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of eyelid, including canthus
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of eyelid, including canthus
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65 | 28 | 37 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 75.37 | 75.82 | 75.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 58
- Matched controls
- 577
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.1
ICD-10 Finland
Carcinoma in situ: Skin of eyelid, including canthus
+∞
80.4
57
*
CBA10
NOMESCO Finland
Biopsy of eyelid
54.6
11.5
13
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
24.6
11.0
15
8
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
133.1
10.8
11
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
133.1
10.8
11
*
L57.0
ICD-10 Finland
Actinic keratosis
7.6
10.2
27
59
TQW99
NOMESCO Finland
Other minor procedure on skin
12.5
10.0
18
20
CBB30
NOMESCO Finland
Excision of lesion of eyelid
37.0
9.8
12
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
19.0
7.6
11
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.2
6.8
19
42
C44.12
ICD-10 Finland
Spinocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.4
6
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.7
6.1
18
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
17
34
6.42
8.70
2.2
1.5
—
—
—
0
0
30
106
4.40
7.87
2.5
1.7
—
—
—
0
0
11
24
5.31
4.99
3.3
1.9
—
—
—
0
0
19
70
3.42
4.39
1.9
1.6
—
—
—
0
0
14
42
3.97
4.33
1.6
1.4
—
—
—
0
0
19
72
3.32
4.18
1.9
1.7
—
—
—
0
0
37
219
2.60
3.48
2.4
2.3
—
—
—
0
0
38
233
2.52
3.25
2.5
2.1
89.1
90.4
pmol/l
0.07
24
110
23
113
2.60
3.11
3.2
1.9
—
—
—
0
0
9
23
4.37
2.90
2.7
1.7
—
—
—
0
0
50
361
2.67
2.85
5.3
4.7
20.2
15.2
mm/h
0.79
44
326
39
254
2.34
2.77
8.9
5.8
1.2
1.2
mmol/l
0.16
33
222
7
15
5.09
2.67
1.4
1.3
—
—
—
0
0
7
15
5.09
2.67
1.4
1.3
—
—
—
0
0
57
456
3.03
2.66
31.4
18.3
35.6
23.6
mg/l
1.13
50
384
10
34
3.29
2.54
3.0
6.3
23.9
25.1
mmol/l
—
10
29
18
87
2.48
2.46
4.3
2.6
0.6
1.1
e6/l
0.44
12
53
58
475
3.05
2.39
33.3
21.4
101.7
86.5
umol/l
0.74
58
475
33
210
2.16
2.37
4.4
3.6
—
—
—
0
0
7
18
4.22
2.32
1.0
1.1
—
—
—
0
0
58
482
2.88
2.22
32.9
21.0
138.9
139.6
mmol/l
0.87
58
465
58
484
2.84
2.21
33.8
20.9
4.0
4.0
mmol/l
0.21
58
466
39
271
2.10
2.17
3.7
2.8
49.5
52.7
u/l
0.13
32
249
9
31
3.20
2.17
3.1
5.4
24.6
25.1
mmol/l
—
9
31
5
10
5.31
2.11
2.0
1.2
—
—
—
0
0
30
191
2.06
2.09
2.7
3.5
2.4
2.3
mmol/l
0.43
25
158
54
434
2.44
1.97
5.6
7.4
39.5
41.7
mmol/mol
0.85
48
396
50
391
2.21
1.93
10.8
7.3
81.7
78.3
u/l
0.37
45
367
5
12
4.41
1.86
1.4
1.4
—
—
—
0
0
53
427
2.31
1.85
28.3
18.2
67.5
70.5
ml/min/173m2
0.44
48
356
16
83
2.23
1.84
11.7
5.1
1.1
1.0
mmol/l
0.37
16
68
51
408
2.16
1.76
4.7
4.5
1.1
1.2
mmol/l
0.36
45
349
53
431
2.24
1.74
5.2
4.9
4.1
4.3
mmol/l
0.86
47
378
56
479
2.22
1.60
16.7
11.4
21.3
23.1
u/l
0.53
51
461
54
449
2.20
1.57
5.8
5.6
2.3
2.5
mmol/l
0.79
48
388
22
137
1.92
1.56
3.2
3.1
394.7
2448.1
umol/l
0.48
16
106
16
89
2.06
1.54
4.8
2.9
0.5
1.3
e6/l
—
10
55
11
53
2.29
1.48
2.7
2.0
334.5
227.8
ng/l
0.29
11
44
24
162
1.76
1.30
6.5
3.3
0.1
0.3
e6/l
1.04
19
125
51
427
1.90
1.29
5.3
5.0
1.4
1.4
mmol/l
0.36
45
370
5
20
2.62
1.17
1.0
1.0
—
—
—
0
0
29
212
1.66
1.16
5.7
3.4
—
—
—
0
0
10
52
2.09
1.13
3.0
7.0
115.6
121.8
g/l
—
10
52
49
417
1.71
1.03
4.6
4.9
2.0
2.0
mu/l
0.06
44
358
7
37
2.00
0.97
1.7
1.2
—
—
—
0
0
23
171
1.53
0.81
2.4
2.3
55.3
61.2
u/l
0.29
18
159
10
59
1.82
0.81
5.0
10.0
—
—
—
0
0
5
23
2.27
0.78
5.2
2.0
—
—
—
0
0
13
85
1.66
0.76
4.7
2.5
19.8
21.8
%
0.26
13
71
13
86
1.64
0.73
4.5
2.4
2.2
2.2
g/l
0.02
13
73
7
42
1.75
0.71
1.1
1.4
—
—
—
0
0
0
23
0.00
0.59
0.0
2.1
—
4.4
—
0
18
49
446
1.40
0.49
5.9
5.4
6.0
6.1
mmol/l
0.15
43
388
7
48
1.51
0.49
1.1
1.3
—
—
—
0
0
5
33
1.56
0.42
1.2
2.6
—
—
—
0
0
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
0
15
0.00
0.42
0.0
2.2
—
—
—
0
0
7
55
1.31
0.31
4.7
4.3
—
—
—
0
0
27
238
1.23
0.29
6.1
4.7
32.3
34.4
ng/l
0.11
21
192
18
207
0.82
0.23
4.5
5.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
11
90
1.27
0.21
2.6
1.8
29.6
30.0
s
0.12
11
83
16
143
1.16
0.13
5.0
2.9
35.0
32.9
u/l
0.20
16
135
8
77
1.04
0.07
1.0
1.2
—
49.0
iu/ml
—
0
25
17
159
1.09
0.06
3.8
4.2
22.8
21.7
%
0.11
12
72
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.8
—
61.0
—
0
5
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_EYELID – Carcinoma in situ of skin of eyelid, including canthus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).